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graded as foLLows: Low-grade (<10 colony forming 
units/miLLiLiter (CFU/mL) and intermediate-grade 
(11-100 CFU/mL) are grouped in Low-bacteriaL Load; 
moderate-grade (101-500 CFU/mL), and high-grade 
(>500CFU/mL) are considered as high-bacteriaL 
Load. 
Results: During 1998, 73% of 1055 and 2004, 82% 
of 1025 BSI were caused by Gram-positive bacteria 
(GPB) with the most frequent being coaguLase- 
negative staphylococcus (CONS), 33% and 50% and 
Staphylococcus aureus, 9% and 6%, respectively. 
In Gram-negative bacterial (GNB) BSI, Enterobac- 
teriacae were common (73%, and 56%) foLLowed 
by non-fermentative (NF)-GNB (37% and 44%); Es- 
cherichia coli (24% and 24%) and Pseudomonas 
areusinosa (17% and 19%) being the most com- 
mon GNB species isolated during 1998 and 2004, 
respectively. A significant increase in the num- 
ber of Stenotrophomonas maltophilia bloodstream 
infection was noted during 6-year study interval 
(6% in 1998 vs. 16% in 2004; P<0.01). Compared 
with GPB infections a significant proportion of GNB 
bacteremia were high-grade (18% vs. 39% in 1998, 
and 7% vs. 44% in 2004; P < 0.001). In contrast to 
1998, in 2004 the non-Pseudomonas NF-GNB in- 
cluding S. maltophilia and Acinetobacter species 
were significantly associated with high-bacteriaL 
Load compared to P. aerusinosa infection (47% vs. 
23%; P--0.05). SimiLarLy, the high-bacteriaL Load 
associated with S. aureus (50%) and Streptococucs 
species (35%)vs. CoNS (13%; P < 0.0001) during 1998 
was not noted during 2004 (22% S. aureus, 20% 
Streptococcus species vs. 21% CONS; P >0.5). This 
was due to a significant increase in CoNS high- 
bacterial Load BSI in 2004 (21% vs. 13% in 1998; 
P < 0.01). There was also an interval increase in 
Corynebacterium species high-bacteriaL Load in- 
fections in 2004 compare to 1998 (18% vs. 5%; 
P<0.01). 
Conclusions: A high proportion of GNB were as- 
sociated with high-bacteriaL Load BSI compared to 
GPB infections. In 2004, a significant increase in 
the S. maltophilia bacteremia was accompanied by 
a concomitant rise in the high-bacteriaL Load BSI, 
which may pose a serious chaLLenge in successful 
therapy in immunosuppressed cancer patients with 
often difficuLt-to-treat systemic GNB infection. 
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Background: Invasive fungaL infection (IFI) remains 
a major cause of morbidity and mortality in cancer 
patients. This is due in part to under diagnosis. 
Previous studies have reported GM-EIA and BG may 
be useful diagnostic tools but the sensitivity is vaM- 
able. We studied the performance of both tests. 
Methods: Between October 2002 and March 2005, 
70 patients were prospectively foLLowed for 12 
weeks. A total of 600 samples were tested in 4 
groups of patients: invasive aspersillosis (IA), other 
mold (FusaMum, zygomycosis, etc.), candidemia, 
and control patients (soLid tumors with no radi- 
oLogicaL, microbioLogicaL or cLinicaL evidence of 
IA). BLood samples were obtained twice on week 
one and once every other week for a total of 
12 weeks. CLinicaL characteristics, including an- 
timicrobiaL therapy, were obtained on aLL patients. 
Testing was performed with serial serum samples 
according to the manufacturer's pecifications. An 
index cut-off for positivity was 0.5 for GM-EIA and 
a serum BG Level of 980 pg/mL was chosen. 
Results: Sensitivity (Sens), specificity (Spec), posi- 
tive predictive value (PPV) and negative predictive 
value (NPV) of the two assays performed on 600 
samples are compared in the table. 
IFI Assay Sens Spec PPV NPV 
Aspergi((osis GM- EIA 0.36 1.00 1.00 0.60 
BG 0.68 0.76 0.75 0.70 
Other mo[d GM-EIA 0.08 1.00 1.00 0.66 
BG 0.75 0.76 0.64 0.84 
Candidemia GM-EIA 0.08 0.95 .50 0.65 
BG 0.67 0.76 0.62 0.80 
Conclusion: BG has better sensitivity than GM-EIA 
in the diagnosis of hematologic patients with IA, 
candidemia and other mold infections. GM might 
be more specific for IA. 
